PlumX Metrics
Embed PlumX Metrics

Peginterferon Alfa-2a for AIDS-associated kaposi sarcoma: Experience with 10 patients

Clinical Infectious Diseases, ISSN: 1058-4838, Vol: 57, Issue: 10, Page: 1497-1499
2013
  • 14
    Citations
  • 0
    Usage
  • 16
    Captures
  • 0
    Mentions
  • 0
    Social Media
Metric Options:   Counts1 Year3 Year

Metrics Details

Article Description

In this observational cohort study, 10 patients with extensive or treatment-refractory AIDS-associated Kaposi sarcoma were treated with peginterferon alfa-2a. Tumor responses were observed in 9 patients with a median progression-free survival of 645 days. Peginterferon alfa-2a could be an effective therapy for extensive or treatment-resistant Kaposi sarcoma. © The Author 2013.

Provide Feedback

Have ideas for a new metric? Would you like to see something else here?Let us know